loader
Please Wait
Applying Filters...
menu
    • menu

    FDA Approvals: Promius Pharma's Sernivo approved in US as topical steroid - Dr. Reddy\'s Laboratories

    MenuDr. Reddy's Laboratories

    Uploaded: 2022
    News
    Semaglutide Patent Expiry Slashes India's Weight-Loss Drug Prices

    25 Feb 2026

    // ECONOMICTIMES

    Biosimilars & innovation are Dr. Reddy’s growth pill

    23 Feb 2026

    // ECONOMICTIMES

    Dr Reddy's Readies Day-1 Launch Of Semaglutide Generic

    18 Feb 2026

    // ECONOMICTIMES

    DATA COMPILATION
    #PharmaFlow

    DRL VB RM

    Contact Supplier

    Website

    DCAT Week

    Lotte New York Palace

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.pharmacompass.com/video-pharmareel/dr-reddys-laboratories/leading-supplier-of-apis-for-40-years
    Xls

    CATEGORY PAGE
    Menu

    Dr. Reddy's Laboratories

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    Key Products KEY PRODUCTS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    PC100302
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.